Castleark Management LLC Veracyte, Inc. Transaction History

Castleark Management LLC

$2.73 Billion
Q4 2024

A detailed history of Castleark Management LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 169,430 shares of VCYT stock, worth $7.13 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

169,430

Previous 176,560 4.04%

Holding current value

$7.13 Million

Previous $6.01 Million 11.67%

% of portfolio

0.25%

Previous 0.25%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $227,589 - $316,572	-7,130 Reduced 4.04%	169,430 $6.71 Million
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $3.71 Million - $6.22 Million	176,560 New	176,560 $6.01 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $1.01 Million - $1.47 Million	51,120 Added 40.22%	178,210 $4.9 Million
Q3 2023 Nov 15, 2023	SELL	$22.33 - $29.92 $30,592 - $40,990	-1,370 Reduced 1.07%	127,090 $2.84 Million
Q2 2023 Aug 15, 2023	BUY	$20.96 - $26.99 $368,057 - $473,944	17,560 Added 15.83%	128,460 $3.27 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $1.65 Million - $2.23 Million	80,130 Added 260.42%	110,900 $2.47 Million
Q4 2022 Feb 09, 2023	BUY	$15.31 - $29.94 $471,088 - $921,253	30,770 New	30,770 $730,000
Q4 2021 Feb 16, 2022	SELL	$36.09 - $53.79 $3.37 Million - $5.02 Million	-93,250 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $3.32 Million - $4.94 Million	93,250 New	93,250 $4.33 Million
Q2 2021 Aug 17, 2021	SELL	$32.94 - $56.62 $6.86 Million - $11.8 Million	-208,257 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $1.94 Million - $3.55 Million	-43,575 Reduced 17.3%	208,257 $11.2 Million
Q4 2020 Feb 17, 2021	BUY	$32.49 - $61.88 $8.18 Million - $15.6 Million	251,832 New	251,832 $12.3 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $7.48 Million - $10.8 Million	-359,722 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$23.87 - $30.93 $1.11 Million - $1.43 Million	-46,330 Reduced 11.41%	359,722 $8.63 Million
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $3.71 Million - $4.79 Million	167,687 Added 70.35%	406,052 $11.6 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $2.86 Million - $6.14 Million	238,365 New	238,365 $5.96 Million

Others Institutions Holding VCYT

# of Institutions

337

Shares Held

80.2M

Call Options Held

212K

Put Options Held

18.5K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.01B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account

Castleark Management LLC Veracyte, Inc. Transaction History